168 related articles for article (PubMed ID: 203419)
1. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
Gertner JM; Brenton DB; Edwards RH
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
Peacock M; Heyburn PJ; Aaron JE
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.
Balsan S; Garabedian M; Courtecuisse V; Guéris J; Dommergues JP; Creignou L; le Denuff MJ; Rivron J
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():225s-230s. PubMed ID: 203417
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
5. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
Peacock M; Heyburn PJ; Aaron JE
Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
[No Abstract] [Full Text] [Related]
6. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
8. Osteomalacia and celiac disease: response to 25-hydroxyvitamin D.
Hepner GW; Jowsey J; Arnaud C; Gordon S; Black J; Roginsky M; Moo HF; Young JF
Am J Med; 1978 Dec; 65(6):1015-20. PubMed ID: 742623
[TBL] [Abstract][Full Text] [Related]
9. The management of siblings with familial hypophosphatemic rickets.
Lapatsanis PD; Sbyrakis S; Megreli C; Edelstein S
Helv Paediatr Acta; 1983 Oct; 38(4):373-81. PubMed ID: 6654689
[TBL] [Abstract][Full Text] [Related]
10. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
Pierides AM; Ellis HA; Simpson W; Cook D; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
[TBL] [Abstract][Full Text] [Related]
11. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
12. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
[TBL] [Abstract][Full Text] [Related]
14. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.
Compston JE; Horton LW; Thompson RP
Gut; 1979 Feb; 20(2):133-6. PubMed ID: 311747
[TBL] [Abstract][Full Text] [Related]
15. Varying role of vitamin D deficiency in the etiology of rickets in young children vs. adolescents in northern India.
Balasubramanian K; Rajeswari J; Gulab ; Govil YC; Agarwal AK; Kumar A; Bhatia V
J Trop Pediatr; 2003 Aug; 49(4):201-6. PubMed ID: 12929879
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
[TBL] [Abstract][Full Text] [Related]
18. Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency.
Reade TM; Scriver CR; Glorieux FH; Nogrady B; Delvin E; Poirier R; Holick F; DeLuca HF
Pediatr Res; 1975 Jul; 9(7):593-9. PubMed ID: 1161348
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency or resistance and hypophosphatemia.
Sarathi V; Dhananjaya MS; Karlekar M; Lila AR
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101876. PubMed ID: 38365463
[TBL] [Abstract][Full Text] [Related]
20. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
Fanconi A; Fischer JA; Prader A
Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
